Grafenia plc Acquisition of Care Management Systems Limited (0990N)
18 Janeiro 2023 - 4:00AM
UK Regulatory
TIDMGRA
RNS Number : 0990N
Grafenia plc
18 January 2023
Prior to publication, the information contained within this
announcement was deemed by the Company to constitute inside
information as stipulated under the UK Market Abuse Regulation.
With the publication of this announcement, this information is now
considered to be in the public domain.
18 January 2023
Grafenia plc
("Grafenia", the "Company" or the "Group")
Acquisition of Care Management Systems Limited ("CMS")
Grafenia plc (AIM: GRA) is pleased to announce that it has
acquired the entire issued share capital of Care Management Systems
Limited, a provider of care home management software and systems,
based in Bristol, on a debt free/cash free basis.
The total consideration of GBP3.5m will be satisfied in cash.
The acquisition is expected to be cash flow generative and earnings
enhancing in the first year after acquisition.
The initial consideration comprises cash of GBP2.975m to be paid
on completion, together with deferred consideration of GBP0.525m to
be paid on the first anniversary of completion.
About Care Management Systems Limited
CMS's care home management software, CareDocs, was initially
developed by brothers Jonathan and Kristopher Ann in 2004 as an
in-house solution for use in a care home owned by family
members.
Having realised the commercial potential for the CareDocs
solution, CMS was founded in 2008 and now licenses its products and
services to over 800 hundred care homes around the UK.
Approximately 95% of CMS's revenues arise from annual recurring
fees.
CMS has an established management team and currently employs 27
staff . Jonathan and Kristopher Ann resigned on completion of the
transaction, with Jonathan remaining on a part-time consultancy
basis for three months to oversee the handover and completion of
certain projects.
The unaudited financial statements for CMS for the year ended 28
February 2022 reported revenue of GBP2.45m, EBIT of GBP0.12m and
closing net assets of GBP1.3m.
Acquisition Rationale
CMS meets Grafenia's acquisition criteria by being a software
business and having a prominent position in its vertical market.
Delivering solutions that generate revenues of a recurring
nature.
Gavin Cockerill , Acting CEO of Grafenia said: "The acquisition
of CMS is our third this financial year. It marks another step
forwards in our transformation plan. Becoming a serial acquirer of
Vertical Market Software b usinesses. We're thrilled to add CMS and
welcome its team to Grafenia's growing portfolio."
Jonathan Ann commented: "When Kristopher and I set about
developing the CareDocs solution we didn't envisage growing a
company that would establish itself as a leading supplier to care
homes in the UK. We're delighted to hand over the reins to the CMS
management team and look forward to seeing the business develop
under Grafenia's ownership."
For further information:
Grafenia plc
Gavin Cockerill (Acting CEO) 07968 510 662
Allenby Capital Limited (Nominated Adviser and broker) 0203 328 5656
David Hart / Piers Shimwell
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ACQGPUUAGUPWUQR
(END) Dow Jones Newswires
January 18, 2023 02:00 ET (07:00 GMT)
Grafenia (LSE:GRA)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Grafenia (LSE:GRA)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025